SULIMAN SHEHNAAZ sold 19.4% of their position (5.72K shares) of 10X GENOMICS, INC. on the open market
Open‑market sale worth $464.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 9/24/2026ACC: 0001610717-26-000422
-5.72K
Net shares
Net seller
$464.7K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
5.72K disposed
Non-Derivative Transactions5
Class A Common Stock
Direct
Shares
−292.00
Price / share
$78.20
Trade value
$22.83K
% of position
1.0%
9/22/2026
29.52K→29.22K
Class A Common Stock
Direct
Shares
−614.00
Price / share
$79.51
Trade value
$48.82K
% of position
2.1%
9/22/2026
29.22K→28.61K
Class A Common Stock
Direct
Shares
−1.32K
Price / share
$80.82
Trade value
$107.08K
% of position
4.6%
9/22/2026
28.61K→27.28K
Class A Common Stock
Direct
Shares
−2.27K
Price / share
$81.67
Trade value
$185.39K
% of position
8.3%
9/22/2026
27.28K→25.01K
Class A Common Stock
Direct
Shares
−1.22K
Price / share
$82.28
Trade value
$100.54K
% of position
4.9%
9/22/2026
25.01K→23.79K
Total
Net shares
−5.72K
Net value
-$464.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/22/2026 | S · Sale | −292.00 | $78.20 | $22.83K | 1.0% | 29.52K | 29.22K |
| Class A Common Stock Direct | 9/22/2026 | S · Sale | −614.00 | $79.51 | $48.82K | 2.1% | 29.22K | 28.61K |
| Class A Common Stock Direct | 9/22/2026 | S · Sale | −1.32K | $80.82 | $107.08K | 4.6% | 28.61K | 27.28K |
| Class A Common Stock Direct | 9/22/2026 | S · Sale | −2.27K | $81.67 | $185.39K | 8.3% | 27.28K | 25.01K |
| Class A Common Stock Direct | 9/22/2026 | S · Sale | −1.22K | $82.28 | $100.54K | 4.9% | 25.01K | 23.79K |
| Total | −5.72K | -$464.67K | ||||||
Derivative Transactions0
No derivative transactions reported